Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NephRx Corp.

This article was originally published in Start Up

Executive Summary

Although no one has yet developed a drug for kidney failure, researchers have long maintained the hope that reversing kidney failure is an attainable goal, because the kidney is one of the few organs in the body capable of regenerating. NephRx Corp. is one of this number of hopefuls; it believes its family of growth factors will repair damaged renal cells, and potentially also serve in degenerative gastrointestinal disorders.

You may also be interested in...



Time-Concepts.com LLC

Time-Concepts.com LLC aims to increase the return on pharmaceutical dollars spent on sales and marketing, with an alternative method for one-on-one physician-sales representative consults that takes advantage of the Internet as a delivery mechanism. The new company hopes to offer benefits to both physicians and pharmaceuticals firms; the former, in providing them with updated information about new drugs and more efficient ways to manage consults with sales representatives, and the latter, with improvements in sales productivity.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

OM013626

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel